These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8999124)

  • 1. Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres.
    Owusu-Ababio G; Rogers JA
    J Microencapsul; 1996; 13(2):195-205. PubMed ID: 8999124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
    Parikh BV; Upadrashta SM; Neau SH; Nuessle NO
    J Microencapsul; 1993; 10(2):141-53. PubMed ID: 8331489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of cephalexin loaded PLGA microspheres.
    Chaisri W; Hennink WE; Okonogi S
    Curr Drug Deliv; 2009 Jan; 6(1):69-75. PubMed ID: 19418958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDLLA microspheres containing steroids: spray-drying, o/w and w/o/w emulsifications as preparation methods.
    Giunchedi P; Alpar HO; Conte U
    J Microencapsul; 1998; 15(2):185-95. PubMed ID: 9532524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.
    Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL
    J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solvent, emulsifier and drug concentration factors in poly(D,L-lactic acid) microspheres containing hexamethylmelamine.
    Hariharan M; Price JC
    J Microencapsul; 2002; 19(1):95-109. PubMed ID: 11811763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
    Uchida T; Yagi A; Oda Y; Goto S
    J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable progesterone microsphere delivery system for osteoporosis therapy.
    Yang Q; Owusu-Ababio G
    Drug Dev Ind Pharm; 2000 Jan; 26(1):61-70. PubMed ID: 10677811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection.
    Gander B; Wehrli E; Alder R; Merkle HP
    J Microencapsul; 1995; 12(1):83-97. PubMed ID: 7730960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
    Pavanetto F; Genta I; Giunchedi P; Conti B
    J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
    Yang YY; Chung TS; Ng NP
    Biomaterials; 2001 Feb; 22(3):231-41. PubMed ID: 11197498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of bioerodible polymeric microspheres and microparticles by rapid expansion of supercritical solutions.
    Tom JW; Debenedetti PG
    Biotechnol Prog; 1991; 7(5):403-11. PubMed ID: 1369363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases.
    Freitas MN; Marchetti JM
    Int J Pharm; 2005 May; 295(1-2):201-11. PubMed ID: 15848005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solvent influence on spray-dried biodegradable microspheres.
    Bain DF; Munday DL; Smith A
    J Microencapsul; 1999; 16(4):453-74. PubMed ID: 10420331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.